DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Extended Phenytoin Sodium is a drug marketed by Amneal Pharms Ny, Ani Pharms Inc, Lupin Ltd, Mylan, Sun Pharm Inds, Sun Pharm Inds (in), Taro, Wockhardt, and Wockhardt Usa. and is included in ten NDAs.
The generic ingredient in EXTENDED PHENYTOIN SODIUM is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
A generic version of EXTENDED PHENYTOIN SODIUM was approved as phenytoin sodium by WEST-WARD PHARMS INT on December 31st, 1969.
Summary for EXTENDED PHENYTOIN SODIUM
Recent Clinical Trials for EXTENDED PHENYTOIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
|Weill Medical College of Cornell University||Phase 4|
|Eisai Inc.||Phase 4|
|Instituto Nacional de Salud Publica, Mexico||Phase 3|